Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RxSpan MD vs HealthRX

RxSpan MD
Graded #10

Level

vs
HealthRX
Graded #9

Level

The verdict

Too close to call — both grade 86/100 (B).

RxSpan MD and HealthRX land on the same WeighScore, so neither clears the other on our six graded dimensions. HealthRX sits one line higher on the board (#9 vs #10) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxSpan MD +1
86
85
Dose & formulationHealthRX +1
89
90
Clinical oversightRxSpan MD +1
88
87
Labs & monitoringRxSpan MD +1
83
82
FulfillmentRxSpan MD +3
89
86
Contract termsEven
85
85
RxSpan MD · left barHealthRX · right bar

The numbers

MetricRxSpan MDHealthRX
WeighScore86/10086/100
GradeBB
Scorecard rank#10#9
SemaglutideFrom $194/mo$189/mo
Tirzepatide$329/mo$349/mo
CoverageAll 50 statesNot publicly listed
Brand-name accessYesYes
Oral / sublingualYesYes
RxSpan MD

Graded #10 · B

Strengths

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
  • Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Published pricing is for the compounded line — brand-name pricing isn’t itemized
  • A prescription isn’t guaranteed — a provider reviews eligibility after checkout
HealthRX

Graded #9 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 34 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard